Crossmark

Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo

Crossref DOI link: https://doi.org/10.1186/s12967-022-03490-9

Published Online: 2022-06-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bei, Roberto https://orcid.org/0000-0001-9541-8896
Benvenuto, Monica

Focaccetti, Chiara

Fazi, Sara

Moretti, Marta

Nardozi, Daniela

Angiolini, Valentina

Ciuffa, Sara

Cifaldi, Loredana

Carrano, Raffaele

Palumbo, Camilla

Miele, Martino Tony

Bei, Riccardo

Barillari, Giovanni

Manzari, Vittorio

De Smaele, Enrico

Modesti, Andrea

Masuelli, Laura
Funding

Funding for this research was provided by:

Università degli Studi di Roma Tor Vergata (E81I18000330005)

Ministero dell'Università e della Ricerca (Prin-E85F22000060006)

Sapienza Università di Roma (#RM11916B74788236)
License Information

Text and Data Mining valid from 2022-06-25

Version of Record valid from 2022-06-25
More Information

Article History

Received: 13 May 2022

Accepted: 16 June 2022

First Online: 25 June 2022

Declarations

:

: The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Document is current

Any future updates will be listed below